Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
2003 1
2004 1
2005 5
2006 4
2007 3
2008 6
2009 8
2010 2
2011 5
2012 5
2013 4
2014 3
2015 3
2016 6
2017 4
2018 5
2019 6
2020 3
2021 7
2022 2
2023 3
2024 1
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study.
Kole TM, Vanden Berghe E, Kraft M, Vonk JM, Nawijn MC, Siddiqui S, Sun K, Fabbri LM, Rabe KF, Chung KF, Nicolini G, Papi A, Brightling C, Singh D, van der Molen T, Dahlén SE, Agusti A, Faner R, Wedzicha JA, Donaldson GC, Adcock IM, Lahousse L, Kerstjens HAM, van den Berge M; ATLANTIS; U-BIOPRED; CADSET investigators. Kole TM, et al. Lancet Respir Med. 2023 Jan;11(1):55-64. doi: 10.1016/S2213-2600(22)00185-0. Epub 2022 Jul 27. Lancet Respir Med. 2023. PMID: 35907424
Leflunomide-associated tuberculosis?
Hocevar A, Rozman B, Praprotnik S, Lestan B, Erzen D, Petric V, Tomsic M. Hocevar A, et al. Among authors: erzen d. Rheumatology (Oxford). 2006 Feb;45(2):228-9. doi: 10.1093/rheumatology/kei173. Epub 2005 Nov 30. Rheumatology (Oxford). 2006. PMID: 16319103 No abstract available.
Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F; EXAMINE Investigators. White WB, et al. N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992602 Free article. Clinical Trial.
Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma: Results from the SysPharmPediA Study.
Shahbazi Khamas S, Van Dijk Y, Abdel-Aziz MI, Neerincx AH, Maarten Blankestijn J, Vijverberg SJH, Hashimoto S, Bush A, Kraneveld AD, Hedman AM, Toncheva AA, Almqvist C, Wolff C, Murray CS, Hedlin G, Roberts G, Adcock IM, Korta-Murua J, Bønnelykke K, Fleming LJ, Pino-Yanes M, Gorenjak M, Kabesch M, Sardón-Prado O, Montuschi P, Singer F, Elosegui PC, Fowler SJ, Brandstetter S, Harner S, Dahlén SE, Potočnik U, Frey U, van Aalderen W, Brinkman P, Maitland-van der Zee AH; SysPharmPediA and U-BIOPRED Consortia. Shahbazi Khamas S, et al. Am J Respir Crit Care Med. 2024 Nov 1;210(9):1091-1100. doi: 10.1164/rccm.202312-2270OC. Am J Respir Crit Care Med. 2024. PMID: 38648186
Beamion BCGC-1: phase Ib/II trial of zongertinib for advanced HER2-positive breast or gastroesophageal cancers.
Hurvitz S, Simonelli M, Yarza R, Berz D, Kitano S, Del Conte G, Acosta Eyzaguirre D, Doger de Speville Uribe BG, Maier D, Erzen D, Aykut Yazgili S, Curigliano G, Deng T, Yan M, Zhang Q, Wang X, Nakayama I, Shitara K. Hurvitz S, et al. Among authors: erzen d. Future Oncol. 2025 Nov;21(26):3385-3393. doi: 10.1080/14796694.2025.2569553. Epub 2025 Oct 17. Future Oncol. 2025. PMID: 41108088 Free PMC article.
Exploring geographic differences in IgE response through network and manifold analyses.
Cucco A, Pearce N, Simpson A, Pembrey L, Mpairwe H, Figueiredo CA, Cooper PJ, Douwes J, Brooks C, Adcock IM, Kermani NZ, Roberts GDM, Murray CS, Custovic A, Fontanella S; WASP Study Group; STELAR/UNICORN Consortium; U-BIOPRED Consortium. Cucco A, et al. J Allergy Clin Immunol. 2025 Jun 30:S0091-6749(25)00702-X. doi: 10.1016/j.jaci.2025.05.032. Online ahead of print. J Allergy Clin Immunol. 2025. PMID: 40602688 Free article.
Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments.
Garcia-Aymerich J, Puhan MA, Corriol-Rohou S, de Jong C, Demeyer H, Dobbels F, Erzen D, Frei A, Gimeno-Santos E, Hopkinson NS, Ivanoff N, Karlsson N, Louvaris Z, Polkey MI, Rabinovich RA, Scuri M, Tabberer M, Vogiatzis I, Troosters T; PROactive consortium. Garcia-Aymerich J, et al. Among authors: erzen d. Thorax. 2021 Mar;76(3):228-238. doi: 10.1136/thoraxjnl-2020-214554. Epub 2021 Jan 21. Thorax. 2021. PMID: 33479044 Free PMC article.
Determinants and outcomes of physical activity in patients with COPD: a systematic review.
Gimeno-Santos E, Frei A, Steurer-Stey C, de Batlle J, Rabinovich RA, Raste Y, Hopkinson NS, Polkey MI, van Remoortel H, Troosters T, Kulich K, Karlsson N, Puhan MA, Garcia-Aymerich J; PROactive consortium. Gimeno-Santos E, et al. Thorax. 2014 Aug;69(8):731-9. doi: 10.1136/thoraxjnl-2013-204763. Epub 2014 Feb 20. Thorax. 2014. PMID: 24558112 Free PMC article.
Validity of activity monitors in health and chronic disease: a systematic review.
Van Remoortel H, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E, Langer D, Glendenning A, Hopkinson NS, Vogiatzis I, Peterson BT, Wilson F, Mann B, Rabinovich R, Puhan MA, Troosters T; PROactive consortium. Van Remoortel H, et al. Int J Behav Nutr Phys Act. 2012 Jul 9;9:84. doi: 10.1186/1479-5868-9-84. Int J Behav Nutr Phys Act. 2012. PMID: 22776399 Free PMC article.
75 results